VASCULARIZATION OF TUMORS
VASCULARIZATION OF TUMORS
复制标题
DOI:
10.1038/scientificamerican0576-58
复制
发表时间:
1976-01-01
影响因子:
3
通讯作者:
FOLKMAN, J
中科院分区:
文献类型:
--
作者:
FOLKMAN, J
In every human being myriads of normal cells are busily reproducing day and night. In an adult at least four million cells divide every second; 350 billion divide in a day; more than 1014 divide in a year. When a normal cell passes through a cycle of division, it has the potential of becoming malignant. Nevertheless, the majority of people go through life without developing a fatal cancer. Clearly the body must possess remarkable control systems for prevent ing aberrant cells from arising or from pro gressing to a terminal malignancy. The cancer statistics give the impression that few if any control systems are at work. In the US about 600,000 new cases of can cer are diagnosed every year, or approxi mately 1,600 every day. Closer analysis pro vides a different perspective. In each person with cancer the tumor probably arises from a single aberrant cell. Since the 2 15 million people in this country generate about 1020 normal cells every day, the probability that a given cell will be a deviant one capable of initiating a tumor is exceedingly small, on the order of one in 1017. How is this extraordinary" quality con trol" accomplished? Why does it fail? How does a lone malignant cell survive? What characteristics must such a survivor acquire to ultimately become a" successful" tumor? Our knowledge is meager. There is some information about control points at the mo lecular level. For example, there are moni toring systems that inspect the DNA of di viding cells and repair breaks, deletions and errors in transcription. There is also some information at the level of individual cells and cell populations. Here I should like to discuss a critical period in the development of solid tumors. For a number of years my colleagues and I have been studying the pe riod after a tiny colony of malignant cells by Judah Folkman has become firmly established but before it has acquired the capacity for rapid prolifer ation and invasiveness. In human beings the in situ lesion is often the earliest stage at which a solid tumor can be detected. Such a lesion is usually only a few millimeters in diameter and semiflattened. If it is present in the skin, the bladder or the cervix, it can be seen and recognized. Similar tumors in other organs of the body cannot be diag nosed at present.At this harmless stage the'tumor is still avascular, that is, it lacks its own network of blood vessels for supplying nutrients, in cluding oxygen, and for removing wastes. Because the transfer of nutrients and wastes has to be accomplished by diffusion through the surrounding healthy tissue the in situ lesion cannot grow beyond a certain vol ume. A steady state is reached in which newly generated cells are balanced by dying cells. In a population that is roughly sphe roidal the steady-state diameter is usually a few millimeters or less. Unless the colony flattens completely into a thin sheet, growth stops. Even tumors that are potentially the most malignant may linger in this" dor mant" stage for years. Since cells within such early microtumors seem to adhere strongly to one another, they usually do not invade, wander through or otherwise vio late the integrity of their host.